Accelrys Announces May 2012 North American User Group Meeting Co-Located With IMACS
Presenters include Abbott, AstraZeneca, Bristol-Meyers Squibb, Eli Lilly, Gartner, Johnson & Johnson, MIT, Perrigo Company and Pfizer
SAN DIEGO, April 30, 2012 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading scientific enterprise R&D software and services company, is pleased to announce that its annual North American User Group Meeting (UGM) is being held from May 7 to 9 at the Marriott Long Wharf Hotel in Boston. The UGM offers attendees a unique forum for discussing industry trends and best practices with colleagues, keynote speakers and Accelrys executives, as well as the opportunity to benefit from expert user presentations, product demonstrations and workshops.
Accelrys' recent acquisition of VelQuest Corporation has extended the company's software portfolio into the downstream pharmaceutical Analytical Development and Quality (ADQ) space. As a result, this year's UGM will predominately feature life sciences presentations and is being co-located with VelQuest's annual International Meeting on Automated Compliance Systems (IMACS). IMACS is a forum for professionals in life sciences industries who are interested in paperless execution and documentation of compliance-based processes to improve operational efficiency and reduce current good manufacturing practice (cGMP) compliance risks. With the UGM focused primarily on life sciences, Accelrys will host dedicated materials science events in the fall of 2012.
"Combining our North American UGM with IMACS enables customers, partners and colleagues to thoroughly explore technology transfer and information flow along the entire lab-to-plant value chain, from product ideation through development and validation to late-stage quality control and production," said Max Carnecchia, president and CEO of Accelrys. "The combined meetings also provide an excellent opportunity to hear more about Accelrys' recent industry-wide call to speed time to market and improve competitiveness by closing the productivity gap from innovation through commercialization."
Further expanding on this industry challenge, this year's keynote address will be delivered by Dr. Jason Bronfeld, executive director, preclinical and pharmaceutical development informatics at Bristol-Meyers Squibb. Bronfeld will present on How Information Management is a Key Enabler for Scientific Innovation.
Accelrys customers, partners and solution experts' presentations comprise a full agenda within five tracks: Analytical Development and Quality; Informatics & Lab Management for Development; Informatics & Lab Management for Research; Modeling & Simulation-Discovery Studio; and Workflow & Automation-Pipeline Pilot.
Currently scheduled presentations include:
- Post-Deployment Review of the eLN Implementation of Symyx Notebook by Accelrys at Pfizer - Angela Chabot, Pfizer
- Use of Symyx Notebook by Accelrys in a GLP Environment - Jennifer Trumbore, Johnson & Johnson
- Data Utilization Across Operations: What Opportunities Exist within the Current Platforms? - Mike Stroz, AstraZeneca
- Business Challenges in a Global Deployment of SmartLab and the Consumable Information Management System - Teresa Lawrence, Eli Lilly & Company
- Combining Nearest Neighbor and Property Based Modeling Methods: Application to In-silico predictions of HT-ADME Data - Rishi Gupta, Abbott
- Implementation of a Lab Execution System: And Now the Rest of the Story - Deborah Baker, Perrigo Company
- Molecular Computational Tools for Designing and Screening of Stable Antibodies - Neeraj Agrawal, MIT
- Industry Forces Impacting the GxP World - Michael Shanler, Gartner, Inc.
Further presentations will be announced leading up to the event. For more information about the 2012 Accelrys North American User Group Meeting with IMACS or to register for the meeting, visit www.accelrys.com/events/ugms/2012/us/.
About Accelrys, Inc.
Accelrys (NASDAQ: ACCL), a leading scientific enterprise R&D software and services company, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad, flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.
Headquartered in San Diego, Calif., Accelrys has more than 1,300 customers in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries and employs approximately 150 full-time Ph.D. scientists. For more information about Accelrys, visit www.accelrys.com.
SOURCE Accelrys, Inc.